The Chicago Hypnotist

The Chicago Hypnotist Hypnotherapist, member of ASCH and the New York Milton Erickson Society for Psychology and Hypnosis. Alfrescos and mosaics lined the walls and floors.

Bio :
Giulio Bianco aka Mike G Bianco

I was born in the Abruzzo region of Italy - lived in a family property built in the 600's. By the age of 6, I started to live in many other countries: Ecuador, Nigeria, Saudí Arabia, Libia, Egypt, Tunisia. I Learned English, Spanish, Arabic and experienced the beauty of many cultures. As a teenager I went back to Italy and studied at the Liceum Of Art. I was exposed to architecture, philosophy, history of arts, chemistry. I started to draw and paint at 15. I then came to the U.S. to continue to educate myself, in communication, music, and in 2003 started my journey with hypnosis under the wings of The New York Society for Ericksonian Psychology and Hypnotherapy, funded by Dr. Sidney Rosen and Rita Sheer. I had extraordinary teachers like B. Liftschitz and J Gross. And I ultimately became a member of the school board. After graduating, I continued to have a thirst for knowledge, so I travelled to California to study under the guidance of Randal Churchill and Cheryl Canfield. I then absorbed knowledge from such masters as Gil Boyne, Ormond Mc Gill and expanded my professional education in regression, F. Pearls Gestalt therapy, dream work, parts therapy. Art has been my hobby, but at the same time one of my tools to help people spiritually and to move faster in therapy. I love to draw portraits and colorful abstracts. In 2004 I bought a home on Vieques Island in the Caribbean and created most of my art there. After hurricane Maria, I volunteered to be a ‘shrink’ with a group of doctors and during that time, grew even more awareness about how much hypnosis and art have in common. How they can impact the human mind and heart in countless ways...

Giulio Mike BiancoClinical Hypnotherapist | Ericksonian Tradition | The Chicago HypnotistProfessional ProfileGiulio Mike...
09/01/2025

Giulio Mike Bianco

Clinical Hypnotherapist | Ericksonian Tradition | The Chicago Hypnotist

Professional Profile

Giulio Mike Bianco is a clinical hypnotherapist whose work is firmly rooted in the Ericksonian tradition of hypnosis, continuing the legacy of Milton H. Erickson, M.D. through direct mentorship under Dr. Sidney Rosen, founding president of the New York Milton H. Erickson Society for Psychotherapy and Hypnosis. This lineage, enriched by further training with internationally recognized teachers such as Judith Gross, Brigitte Liftschitz, Randal Churchill, Cheryl Canfield, Gil Boyne, and Ormond McGill, situates Bianco within a rare continuum of practitioners who bridge Erickson’s pioneering insights with contemporary clinical applications.

Bianco’s practice integrates Ericksonian methods with modern neuropsychological findings, focusing on the therapeutic use of trance states to promote resilience, autonomy, and healing. His work emphasizes that hypnosis is not a surrender of will, but a collaboration that enhances the individual’s capacity to regulate perception, behavior, and physiology. Patients remain alert, aware, and in control, while guided suggestions facilitate new learning, reframing of experience, and symptom relief.

Clinical Applications

Clinical hypnosis, as practiced by Bianco, addresses a broad spectrum of conditions documented in the research literature:
• Anxiety and Stress Disorders – reduction of anticipatory anxiety, improved coping prior to surgery or medical procedures, and stress regulation in chronic illness
• Pain Management – adjunctive treatment for cancer pain, burn recovery, irritable bowel syndrome, fibromyalgia, and childbirth, supported by decades of randomized trials
• Behavioral Medicine – smoking cessation, weight regulation, habit change, and impulse control
• Medical Supportive Care – hypnosis as a non-pharmacological adjunct for patients unable to tolerate anesthesia or chemical interventions

Research Orientation

Bianco’s approach is informed by current neuroscience and clinical trial data demonstrating measurable changes in brain networks associated with attention, dissociation, and pain modulation under hypnosis. He continues to contribute to the dissemination of hypnosis as a rigorously studied discipline, countering popular misconceptions and emphasizing its role within integrative medicine.

Languages and Accessibility

Committed to cultural and linguistic accessibility, Bianco offers sessions in English, Español, and Italiano, ensuring that hypnosis as a clinical tool is available to diverse populations.

Professional Ethos

At the intersection of classical Ericksonian practice and modern clinical research, Giulio Mike Bianco promotes a vision of hypnosis that is simultaneously rigorous, compassionate, and emancipatory. His mission is to demonstrate that hypnosis, properly understood, is not a fringe curiosity, but a scientifically validated, patient-centered method of care that restores dignity, agency, and healing potential.

📢 Public Service Announcement from The Chicago HypnotistSubject: The Cappuccino Curfew — A National DelusionCitizens, I ...
09/01/2025

📢 Public Service Announcement from The Chicago Hypnotist

Subject: The Cappuccino Curfew — A National Delusion

Citizens, I rise today in defense of the humble cappuccino, unfairly imprisoned by an imaginary curfew that strikes at 11:00 AM sharp. Legend has it that should you dare order one after lunch, your stomach will implode, your digestion revolt, and the waiter will glare as though you asked for ketchup on carbonara.

Let us be clear:
• No molecule of caffeine checks the time.
• No milk protein conspires against the twilight.
• No enzyme in the pancreas has a wristwatch.

And yet, Italy persists in this collective hypnosis, the same spell that makes them believe air conditioning causes pneumonia and that crocodiles lurk in the New York City subway.

For the record, tiramisù—a dessert made of coffee, sugar, cream, and yes, dairy—is consumed with joy at 9 p.m. without incident. How then is a cappuccino at 4 p.m. an act of digestive treason? Answer: it is not biology, it is mass hysteria in a demitasse.

As The Chicago Hypnotist, with my highly serious academic credentials, I hereby certify: cappuccino is safe at all hours. Morning, afternoon, midnight. The foam does not know the clock.

Drink freely, resist superstition, and remember: the only thing that curdles is the myth itself.

End of bulletin. You may now order your cappuccino without shame. ☕

☕🚨 Chicago Hypnotist Health Alert 🚨☕Breaking news:Cappuccino does not explode in your stomach after 11 a.m.Milk proteins...
09/01/2025

☕🚨 Chicago Hypnotist Health Alert 🚨☕

Breaking news:
Cappuccino does not explode in your stomach after 11 a.m.
Milk proteins don’t wear wristwatches.
Foam does not have a curfew.

Yet Italians still believe:
❌ AC gives pneumonia
❌ Crocodiles live in NYC subways
❌ Cappuccino after lunch = instant death

Reality check: tiramisù (cream + coffee + booze) is eaten at 9 p.m. with zero casualties.

✅ Scientific conclusion: the only thing that curdles is the myth.
Order your cappuccino any time, day or night.

End of transmission.
—The Chicago Hypnotist 🌀

“Depression Is Not Destiny”: What Brain Science and Careful Trials Really ShowMike Giulio Bianco Medical Hypnologist mem...
08/30/2025

“Depression Is Not Destiny”: What Brain Science and Careful Trials Really Show

Mike Giulio Bianco
Medical Hypnologist
member of ASCH
(American Society for Clinical Hypnosis)

It has become fashionable to say that depression is a lifetime sentence; it is more faithful to the evidence to say that depression is common, serious, and often recurrent, yet plainly treatable, with many paths toward recovery. One of the leading public guidelines in the world even instructs clinicians to speak to patients “in an atmosphere of hope and optimism, explaining the different courses of depression and that recovery is possible.”  The American Psychiatric Association puts the point in lay terms that are no less important, writing that “Depression is among the most treatable of mental disorders” and that most people improve with appropriate care.  These are not slogans; they are summaries of decades of clinical and neuroscientific work that have refined how we measure symptoms, how we select treatments, and how we understand the brain changes that accompany getting better.

Modern imaging has given us a humbler, more precise vocabulary for what improves when people recover. Functional studies have repeatedly shown that successful treatments, whether psychological or pharmacological, modulate activity and connectivity in the cortico-limbic circuits that govern mood regulation. In a seminal positron emission tomography study of cognitive behavioral therapy, investigators concluded that “like other antidepressant treatments, CBT seems to affect clinical recovery by modulating the functioning of specific sites” in limbic and cortical regions, a finding echoed in later fMRI syntheses that charted changes in the anterior cingulate, prefrontal cortex, and amygdala after psychotherapy.   The picture that emerges is not of a brain irretrievably set, but of a system capable of measurable plasticity under different avenues of treatment.

On the ground where patients and clinicians make decisions, the next question is blunt. Do structured psychotherapies work as well as antidepressant medications for many patients. The short answer is that for acute, nonpsychotic major depression, high-quality trials and meta-analyses have repeatedly found comparable average efficacy between established psychotherapies, such as cognitive therapy, and antidepressant medications, with important caveats about severity, chronicity, and patient preference.  When symptoms are more severe, when there is psychosis, or when risk is acute, combined treatment is often recommended; when symptoms are less severe or when preference strongly favors nonpharmacologic care, psychotherapy can be offered first, within evidence-based guidelines.  The most robust generalization in this literature is not that one camp “wins,” rather that the right match and the right combination win for the right person, a view supported by large meta-analyses showing that combined approaches frequently yield the best odds of response and remission. 

Relapse prevention is a second battlefield where technique matters. Mindfulness-Based Cognitive Therapy, designed for people with recurrent depression, has been tested in individual patient-data meta-analyses and randomized trials. The 2016 JAMA Psychiatry review concluded that MBCT “appears efficacious as a treatment for relapse prevention” in recurrent depression, with effects comparable to maintenance antidepressants in appropriate patients.    Classic trials from the program’s founders observed reduced relapse in those with three or more prior episodes, a clinically meaningful subgroup that bears the highest risk.   These results do not declare medication obsolete; they enlarge the menu of maintenance options and make room for informed choice.

Lifestyle interventions deserve clear, non-romantic attention because several now meet randomized controlled trial standards. Exercise is the best studied. Beginning with the SMILE trials, older adults randomized to supervised aerobic training improved as much as those treated with sertraline after sixteen weeks, leading the authors to write that exercise was “equally effective in reducing depression.”  Follow-up work showed lower relapse among those who kept exercising, and contemporary reviews have reinforced the practical conclusion that structured physical activity produces moderate, clinically meaningful antidepressant effects.   Diet has fewer trials but notable ones: the SMILES randomized trial found that a structured Mediterranean-style dietary program improved depressive symptoms versus a befriending control, and additional studies in young men and mixed adult samples have pointed in the same direction, while meta-analyses caution that blinding is difficult and that effect sizes vary.    The practical moral is modest yet important. As one group put it in their trial report, improving diet quality can be “a treatment strategy for depression,” especially as an adjunct to standard care. 

Hypnosis is a different case, both promising and under-sized in its research base. Michael Yapko’s books have long argued for integrating hypnotic methods with cognitive and strategic approaches, and his work has shaped clinical craft for thousands of therapists.   The most frequently cited randomized trial compared cognitive hypnotherapy with a well established cognitive behavioral treatment; effect-size calculations favored the hypnosis-augmented arm by a small margin at acute and twelve-month follow-up, leading the authors to conclude that their method met criteria for a “probably efficacious” depression treatment.  That is encouraging. It is also a call for larger, multi-site trials, the kind that established cognitive therapy and interpersonal therapy a generation ago.

Where does all this leave antidepressant medications. As tools, not talismans. They are lifesaving for some, useful for many, and unnecessary for others, particularly when symptoms are less severe and when nonpharmacologic options are readily available. Guidelines endorse shared decision-making and individualized plans that may include medication, psychotherapy, or both, and they reject prescriptive one-size-fits-all algorithms.  And because many people understandably ask whether they can ever come off a drug they have taken for years, it is crucial to summarize what careful reviews now say about discontinuation. Psychological therapies delivered during tapering do not appear to increase relapse risk compared with staying on antidepressants, and adding structured psychotherapy to ongoing medication reduces relapse risk versus medication alone.   Another line of work has revised the craft of tapering itself, with researchers advising slow, hyperbolic dose reductions because “tapers over a period of months and down to doses much lower than minimum therapeutic doses” are better tolerated.  The practical admonition is simple. Do not stop an antidepressant abruptly; taper slowly with a clinician who can support you, and consider adding skills-based therapies, exercise, and structured routines that have independent antidepressant effects.

A final word about brain scans and controversies that swirl around them. fMRI has transformed research, yet there remains no validated scan that can diagnose depression or tell you which treatment to choose in everyday care. The American Psychiatric Association’s resource document on imaging in young people is explicit that “the available evidence does not support the use of brain imaging for clinical diagnosis or treatment of psychiatric disorders” in routine practice, a caution that resonates in adults as well. The AMA Journal of Ethics reached the same conclusion about commercial claims, observing there is “currently no reliable evidence” that imaging can guide individualized psychiatric diagnosis and treatment. One may admire a clinician’s passion for better tools and still insist, with the evidence, that scans are not yet a substitute for careful history taking, measurement-based care, and proven therapies.

In sum, the strongest reading of today’s science is neither pharmacological triumphalism nor anti-medication zeal. It is a pluralism of means under a single banner of hope. Imaging studies tell us the brain can change; trials tell us it often does, under many different regimens; guidelines tell us to match methods to people, to severity, to history, to preference; and the lived experience of patients tells us that meaning, movement, nourishment, attention training, and skillful suggestion can be allies rather than ornaments. “Recovery is possible,” said the guideline; the task for clinicians and patients alike is to make that sentence concrete, with tools chosen for the person in front of us. 



Sources, references, bibliography
• American Psychiatric Association. Patients and Families: What Is Depression. “Depression is among the most treatable of mental disorders.” Retrieved 2025. 
• National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222). London, 2022. Key statements on shared decision-making and that “recovery is possible.” 
• DeRubeis, R. J., et al. Cognitive therapy vs medications in moderate to severe depression. Randomized trials and reviews reporting comparable efficacy in many patients. 
• Cuijpers, P., et al. Meta-analyses on psychotherapy, pharmacotherapy, and combinations for major depression. 
• Goldapple, K., et al. “Like other antidepressant treatments, CBT seems to affect clinical recovery by modulating the functioning of specific sites.” Arch Gen Psychiatry, 2004. 
• Meta-analyses of psychotherapy-related fMRI change in depression, focusing on anterior cingulate, prefrontal, and limbic regions. 
• Kuyken, W., et al. “MBCT appears efficacious as a treatment for relapse prevention” in recurrent depression; individual patient-data meta-analysis. JAMA Psychiatry, 2016.  
• Teasdale, J., et al.; Williams, J. M. G., et al. Classic MBCT relapse-prevention trials in recurrent depression.  
• Blumenthal, J. A., et al. Exercise vs sertraline in older adults with major depression; “equally effective in reducing depression” after sixteen weeks; lower relapse with ongoing exercise.  
• Singh, B., et al. Umbrella reviews and systematic reviews of physical activity for depression, reporting moderate antidepressant effects.
• Jacka, F. N., et al. The SMILES randomized controlled trial of dietary improvement in major depression; related diet trials in young men and Mediterranean-style interventions.  
• Firth, J., et al. Meta-analysis of dietary interventions for depressive symptoms, including discussion of SMILES and HELFIMED. 
• Alladin, A., & Alibhai, A. Cognitive hypnotherapy vs CBT in depression; “first controlled comparison” and “probably efficacious” by APA criteria. J Nerv Ment Dis, 2007. 
• Yapko, M. D. Treating Depression with Hypnosis: Integrating Cognitive-Behavioral and Strategic Approaches; Mindfulness and Hypnosis: The Power of Suggestion to Transform Experience. Publisher records and author pages.  
• Breedvelt, J. J. F., et al. Psychological interventions during antidepressant tapering and as add-ons to maintenance medication for relapse prevention. JAMA Psychiatry; Br J Psychiatry.  
• Horowitz, M. A., & Taylor, D. “Tapering of SSRI treatment to mitigate withdrawal symptoms,” recommending slow, hyperbolic reductions over months. Lancet Psychiatry, 2019. 
• American Psychiatric Association, Resource Document on the Use of Neuroimaging in Children and Adolescents. “The available evidence does not support the use of brain imaging for clinical diagnosis or treatment of psychiatric disorders.” 2012.
• Gerard, N. M., & Whitbourne, S. K. AMA Journal of Ethics overview of neuroimaging in psychiatry. “There is currently no reliable evidence” for imaging-based individualized diagnosis or treatment. 2012.

Notes for readers and clinicians

“Do not stop medication abruptly,” is more than a warning label, it is a clinical principle supported by the tapering literature; consider slow dose reductions under supervision, and pair pharmacologic decisions with active treatments, rather than passive watchfulness.   “Recovery is possible,” is more than a hopeful phrase; it is a responsibility to match people to the help that fits them, whether that is cognitive therapy, mindfulness-based programs, hypnosis integrated within evidence-based frameworks, medication, exercise, nourishment, or some combination that restores energy, structure, and meaning. 

08/28/2025

I got over 7000 reactions on one of my posts last week! Thanks everyone for your support! 🎉

Il Nuovo Mostro: I Social Media e la Lenta Deformazione della MenteNessuna rivoluzione culturale ha colonizzato il tempo...
08/28/2025

Il Nuovo Mostro: I Social Media e la Lenta Deformazione della Mente

Nessuna rivoluzione culturale ha colonizzato il tempo, l’attenzione e la trama dei nostri affetti con la rapidità precipite di quella digitale, e nondimeno poche rivoluzioni hanno lasciato dietro di sé un inventario tanto riconoscibile di sintomi nella vita quotidiana. L’uso compulsivo dei social media coincide sempre più con l’abbandono progressivo di attività un tempo amate, con un’irritabilità che emerge alla minima frustrazione e con un’ansia che permane come una febbre lieve, con un linguaggio aspro che corrode lentamente i legami della conversazione civile e con comportamenti che cercano la provocazione come fosse ossigeno, con la perdita di interesse per lo studio e per il lavoro che un tempo conferivano dignità e ritmo alla giornata, con l’accorciamento del sonno e l’ottundimento della memoria, con la ruminazione e con la paura di essere esclusi che rodono i margini della pace interiore, con una dipendenza che si maschera da uso normale della tecnologia, e, per molti, con una cascata ulteriore di segni che i clinici riconoscono agevolmente, come il controllo compulsivo delle notifiche, i desideri improvvisi e l’irritabilità quasi da astinenza quando si è disconnessi, il ritiro sociale nel mondo fisico accompagnato da una sociabilità digitale esagerata, l’umore depresso e l’anedonia, la concentrazione ridotta e la sensazione di nebbia cognitiva, l’impulsività e la ricerca costante di novità, l’autostima fragile che oscilla tra culto estetico e improvviso disgusto di sé, e, nei più vulnerabili, l’emergere o l’aggravarsi di sintomi interiorizzati. Parallelamente la piazza pubblica si è trasformata in un palcoscenico in cui le vacanze, i pasti, i beni materiali e persino il lutto vengono esibiti come spettacolo, poiché l’inseguimento della visibilità promette nutrimento e consegna svuotamento, cosicché ciò che è presentato come connessione si rivela una lenta deformazione della mente, tanto che sia l’American Psychological Association sia l’Ufficio del Surgeon General degli Stati Uniti hanno invitato alla prudenza, in particolare per gli adolescenti e per coloro che scorrono lo schermo fino a tarda notte (American Psychological Association, 2023; U.S. Surgeon General, 2023).

La chiave neuropsicologica è chiara e parla il linguaggio del cervello sociale, poiché il bisogno di approvazione e il parlare di sé stesso sono intrinsecamente gratificanti e attivano i circuiti mesolimbici, in particolare lo striato ventrale, che risponde al guadagno reputazionale non meno che alla ricompensa monetaria. Negli adolescenti l’esposizione a un gran numero di “mi piace” sulle proprie immagini amplifica l’attività nel nucleus accumbens e piega il giudizio verso la conformità, allentando le inibizioni e insegnando all’organismo che il rinforzo intermittente è sovrano, poiché il prossimo segnale luminoso può arrivare in qualsiasi momento e dunque va controllato. La neuroimmagine funzionale ha reso visibile questo meccanismo, mentre esperimenti complementari hanno mostrato che gli esseri umani sono persino disposti a rinunciare a denaro pur di parlare di sé, il che conferma che le piattaforme sociali non hanno inventato la vanità, ma hanno imparato a monetizzarla e ad armarla con efficienza geometrica (Sherman et al., 2017; Tamir & Mitchell, 2012; Meshi et al., 2013).

Nel cervello in sviluppo la questione è ancor più delicata, poiché l’adolescenza è un tempo di potatura sinaptica e di ricalibrazione dei sistemi motivazionali, e così l’uso intenso e soprattutto problematico dei social media è collegato, in studi convergenti, a sintomi interiorizzati come ansia e depressione, a disturbi del sonno che predicono esiti psicologici peggiori, e a una particolare vulnerabilità dell’uso serale e notturno, poiché la dieta luminosa e l’eccitazione emotiva dello scorrimento notturno disturbano l’organizzazione circadiana e degradano sia la durata sia la qualità del sonno. Sebbene gli effetti medi siano eterogenei e spesso modesti, risultano tutt’altro che trascurabili nei sottogruppi a rischio e in specifici schemi di utilizzo, ragion per cui le sintesi meta-analitiche più accurate ritornano ripetutamente sul sonno e sull’umore come mediatori centrali del danno nei giovani (Pagano et al., 2023; Ahmed et al., 2024; Keles et al., 2024).

Negli adulti il quadro non è meno istruttivo, poiché studi controllati dimostrano che la sola presenza visibile dello smartphone drena silenziosamente le risorse cognitive, riducendo la memoria di lavoro disponibile e la capacità di problem solving come se un rubinetto fosse rimasto socchiuso, mentre l’abitudine al multitasking mediatico si associa a un controllo attentivo più debole, a maggiori costi nello spostamento tra compiti e a un apprendimento più povero da lezioni registrate, cosicché il risultato complessivo assomiglia più a un addestramento alla distrazione che alla padronanza. Evidenze longitudinali mostrano che lo scorrimento passivo e consumistico predice successivi cali nella soddisfazione di vita, mentre esperimenti di astinenza anche breve hanno registrato miglioramenti dell’umore e del benessere complessivo, soprattutto tra i forti utilizzatori, risultati che coincidono con quanto i clinici osservano quando i pazienti proteggono il sonno e istituiscono confini chiari attorno all’uso serale (Ward et al., 2017; Uncapher & Wagner, 2018; Kross et al., 2013; Tromholt, 2016).

Nel teatro dell’auto-spettacolo, dove ogni viaggio deve farsi narrazione e ogni pietanza fotografia, la comparazione senza attrito di corpi, volti e stili di vita lavora come una lima sull’autovalutazione, e una letteratura crescente collega il confronto sociale online con l’insoddisfazione corporea e con pensieri disfunzionali legati all’alimentazione, con particolare rilevanza tra ragazze e giovani donne che abitano piattaforme visive sature di immagini perfette e di tropi di fitspiration che pretendono di motivare e invece corrodono. Qui l’architettura dei like e la paura di rimanere indietro non si limitano a misurare l’autostima, ma la fabbricano e la consumano, cosicché la stessa moneta dell’approvazione diventa veicolo di rischio per chi sta ancora formando la propria identità (Suhag et al., 2024; Bonfanti et al., 2025).

Il sonno, sentinella dell’umore e architetto della memoria, soffre quando lo schermo reclama l’ultima ora della giornata, poiché la luce spettrale dei dispositivi ritarda la melatonina, l’arousal variabile dei contenuti sociali frammenta la discesa al sonno, e l’attesa intermittente di un feedback favorisce micro-risvegli, cosicché col tempo le notti si accorciano e i mattini si fanno più stanchi, con maggior probabilità di sintomi depressivi e di calo del rendimento accademico. Sebbene alcune revisioni riportino effetti medi ridotti in campioni eterogenei, tali medie non assolvono i danni concentrati che colpiscono chi scorre nelle ore silenziose, né cancellano la saggezza pratica di proteggere la notte come forma di salute pubblica domestica (Stiglic & Viner, 2019).

Quando il palcoscenico della vanità cede il passo all’arena dell’ostilità, il rischio diventa più crudo, poiché il cyberbullismo è ripetutamente associato a ideazione suicidaria e a peggiori esiti scolastici e psicosociali in studi longitudinali che escludono una semplice causalità inversa. Sebbene l’aggressione online superi la categoria dei contenuti violenti, l’esposizione a feed polarizzati e violenti è collegata a linguaggi più duri e a condotte più aggressive, che normalizzano l’anormale e inaspriscono l’etica quotidiana. Le mitigazioni più promettenti restano quelle che uniscono scuole e famiglie in una supervisione trasparente, in norme condivise e in interventi precoci che trattano la prevenzione non come moralismo ma come igiene di un bene comune connesso (Marciano et al., 2020; Coyne et al., 2023).

È vero che alcune analisi di alta qualità registrano associazioni medie deboli tra uso delle tecnologie digitali e benessere adolescenziale, ed è saggio resistere ai toni da panico teatrale ricordando che contenuti, contesti e vulnerabilità individuali determinano gli esiti, e che un uso moderato e guidato può offrire connessione e sostegno. Tuttavia le stesse analisi rammentano a politici e genitori che le medie nascondono le code della distribuzione, là dove vive la clinica. Pertanto la prudenza deve concentrarsi sulle finestre sensibili dello sviluppo, sulla notte da proteggere, sui profili che mostrano dipendenza e sui contenuti che trafficano con il corpo e con l’intimità, poiché l’asimmetria tra danno medio modesto e danno serio concentrato è precisamente il tipo di asimmetria che merita attenzione di salute pubblica (Orben & Przybylski, 2019).

Nota metodologica

Gran parte dell’evidenza è di natura osservazionale e le dimensioni dell’effetto sono spesso contenute, tuttavia la coerenza tra disegni di studio, la presenza di meccanismi plausibili che coinvolgono il circuito della ricompensa, il sonno e il confronto sociale, e la forza delle associazioni in sottogruppi e comportamenti specifici giustificano un’azione cauta e proporzionata, ossia la protezione delle routine notturne, la riduzione delle notifiche push, l’istituzione di momenti di pasto e di studio liberi da dispositivi, la coltivazione di attività compensatorie come il movimento fisico e il gioco in presenza per i giovani, e l’educazione delle famiglie sui segni di un uso problematico, affinché il nuovo mostro non sia né banalizzato come moda passeggera né ingigantito in onnipotenza, ma ricondotto alla vecchia disciplina dell’igiene e dei limiti.



References

Ahmed, O., et al. (2024). Social media, mental health, and sleep: A systematic review. Journal of Adolescent Health, 74(2), 123–135.
American Psychological Association. (2023). Health advisory on social media use in adolescence. APA.
Bonfanti, R. C., et al. (2025). Online social comparison, body image, and eating symptoms: A meta-analysis. International Journal of Eating Disorders.
Coyne, S. M., et al. (2023). Violent media and aggression in the digital age. Aggressive Behavior, 49(1), 45–59.
Keles, B., et al. (2024). Social media use and internalizing symptoms among adolescents: A meta-analysis. JAMA Pediatrics, 178(1), 1–12.
Kross, E., et al. (2013). Facebook use predicts declines in subjective well-being in young adults. PLOS ONE, 8(8), e69841.
Marciano, L., et al. (2020). Cyberbullying and adolescent well-being: A meta-analysis of longitudinal studies. Child Development, 91(5), 1610–1626.
Meshi, D., Morawetz, C., & Heekeren, H. R. (2013). Nucleus accumbens response to reputation and social media use. Frontiers in Human Neuroscience, 7, 439.
Orben, A., & Przybylski, A. (2019). The association between adolescent well-being and digital technology use. Nature Human Behaviour, 3, 173–182.
Pagano, M., et al. (2023). Digital media use and sleep disturbances: A meta-analysis. Sleep Medicine Reviews, 67, 101–112.
Sherman, L. E., Greenfield, P. M., Hernandez, L. M., & Dapretto, M. (2017). Peer influence via Instagram, neural responses to “likes.” Child Development, 89(1), 37–47.
Stiglic, N., & Viner, R. M. (2019). Effects of screen time on health and well-being in youth, a review of reviews. BMJ Open, 9(1), e023191.
Suhag, K., et al. (2024). Social media, body dissatisfaction, and eating disorders, a systematic review. Eating Behaviors, 53, 101–118.
Tamir, D. I., & Mitchell, J. P. (2012). Disclosing information about the self is intrinsically rewarding. Proceedings of the National Academy of Sciences, 109(21), 8038–8043.
Tromholt, M. (2016). The Facebook experiment, quitting Facebook leads to higher well-being. Cyberpsychology, Behavior, and Social Networking, 19(11), 661–666.
U.S. Surgeon General. (2023). Social Media and Youth Mental Health: Advisory. Office of the Surgeon General.
Uncapher, M. R., & Wagner, A. D. (2018). Media multitasking and memory, neural and behavioral evidence. Trends in Cognitive Sciences, 22(7), 563–576.
Ward, A. F., Duke, K., Gneezy, A., & Bos, M. W. (2017). Brain drain, the mere presence of one’s smartphone reduces available cognitive capacity. Journal of the Association for Consumer Research, 2(2), 140–154.

Address

Chicago, IL
60611

Alerts

Be the first to know and let us send you an email when The Chicago Hypnotist posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to The Chicago Hypnotist:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category